A proposed Senate bill limits the amount of opioids a patient can initially receive for acute pain. If passed, physicians will only be able to prescribe seven days’ worth of opioids when first treating a patient’s condition.
Remind nurses and other clinicians to remain alert for medication errors, including mislabeled products. And empower them to say something if they suspect a problem.
The World Health Organization (WHO) announced a new global initiative earlier this month, one that aims to halve the rate of medication errors by 2022.
To best promote patient safety, it is crucial to seek out information about external errors, to hold on to your initial feelings of surprise and uncertainty when you read about these errors, and to resist the temptation to gloss over what happened or attribute the problem to an individual different than you.
The Institute for Safe Medication Practices (ISMP) released its 2016–2017 Targeted Medication Safety Best Practices for Hospitals guide in December 2015. This year there were five new best practices and two revised out of 11 total.
The just-departed commissioner of the Food and Drug Administration has concerns about plans to speed up drug approvals and dramatically reduce regulations at the agency, as advocated recently by President Donald Trump.
More hospitals and health systems are waking up to the risks of under-monitoring patients at risk for respiratory depression.
The problem: Today, several longstanding medications are available on the market with names that begin with the prefix “Depo-,” meaning they are administered via a depot injection that deposits the drug into localized tissue from which it is gradually absorbed by surrounding tissue.
Efforts to improve patient safety are paying off, according to a new Health and Human Services (HHS) department report.
Smart pump–EMR interoperability is the new standard of care for intravenous (IV) infusion therapy. The IV route of administration for medications often results in the most serious outcomes of medication errors.